Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride
Creators
- 1. Jikei University School of Medicine, Department of Psychiatry, Tokyo (Japan)
- 2. National Institute of Radiological Sciences, Molecular Neuroimaging Program, Molecular Imaging Center, Chiba (Japan)
- 3. National Institute of Radiological Sciences, Biophysics Program, Molecular Imaging Center, Chiba (Japan)
- 4. Karolinska Institutet, Department of Clinical Neuroscience, Stockholm (Sweden)
Description
Dopamine D2/3 receptors (D2/3Rs) have two affinity states for endogenous dopamine, referred to as high-affinity state (D2/3HIGH), which has a high affinity for endogenous dopamine, and low-affinity state (D2/3LOW). The density of D2/3HIGH can be measured with (R)-2-11CH3O-N-n-propylnorapomorphine ([11C]MNPA), while total density of D2/3HIGH and D2/3LOW (D2/3Rs) can be measured with [11C]raclopride using positron emission tomography (PET). Thus, the ratio of the binding potential (BP) of [11C]MNPA to that of [11C]raclopride ([11C]MNPA/[11C]raclopride) may reflect the proportion of the density of D2/3HIGH to that of D2/3Rs. In the caudate and putamen, [11C]MNPA/[11C]raclopride reflects the proportion of the density of D2HIGH to that of D2Rs. To evaluate the reliability of the PET paradigm with [11C]MNPA and [11C]raclopride, we investigated the test-retest reproducibility of non-displaceable BP (BPND) measured with [11C]MNPA and of [11C]MNPA/[11C]raclopride in healthy humans. Eleven healthy male volunteers underwent two sets of PET studies on separate days that each included [11C]MNPA and [11C]raclopride scans. BPND values in the caudate and putamen were calculated. Test-retest reproducibility of BPND of [11C]MNPA and [11C]MNPA/[11C]raclopride was assessed by intra-subject variability (absolute variability) and test-retest reliability (intraclass correlation coefficient: ICC). The absolute variability of [11C]MNPA BPND was 5.30 ± 3.96 % and 12.3 ± 7.95 % and the ICC values of [11C]MNPA BPND were 0.72 and 0.82 in the caudate and putamen, respectively. The absolute variability of [11C]MNPA/[11C]raclopride was 6.11 ± 3.68 % and 11.60 ± 5.70 % and the ICC values of [11C]MNPA/[11C]raclopride were 0.79 and 0.80 in the caudate and putamen, respectively. In the present preliminary study, the test-retest reproducibility of BPND of [11C]MNPA and of [11C]MNPA/[11C]raclopride was reliable in the caudate and putamen. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-012-2312-8Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 40
- Journal Issue
- 4
- Journal Page Range
- p. 574-579
- ISSN
- 1619-7070
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 44105762
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- AFFINITY; BRAIN; CARBON 11; CHEMORECEPTORS; COMPUTERIZED TOMOGRAPHY; DOPAMINE; IMAGE PROCESSING; LIGANDS; NMR IMAGING; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RELAXATION TIME; RELIABILITY; SPATIAL DISTRIBUTION; WEIGHTING FUNCTIONS
- Descriptors DEC
- AMINES; AROMATICS; AUTONOMIC NERVOUS SYSTEM AGENTS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CARBON ISOTOPES; CARDIOTONICS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISTRIBUTION; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EVEN-ODD NUCLEI; FUNCTIONS; HYDROXY COMPOUNDS; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MINUTES LIVING RADIOISOTOPES; NERVOUS SYSTEM; NEUROREGULATORS; NUCLEI; ORGANIC COMPOUNDS; ORGANS; PHENOLS; POLYPHENOLS; PROCESSING; RADIOACTIVE MATERIALS; RADIOISOTOPES; SYMPATHOMIMETICS; TOMOGRAPHY